Boris Freydin

616 citations
17 papers · 470 indexed · h-index 10
Topics
Cancer Cells and Metastasis (4 papers)Cytokine Signaling Pathways and Interactions (4 papers)Pancreatic and Hepatic Oncology Research (3 papers)

In The Last Decade

Boris Freydin

16 papers receiving 463 citations

Peers

Boris Freydin
Comparison fields: 5 of 67
  • Oncology 274
  • Molecular Biology 241
  • Cancer Research 117
  • Genetics 68
  • Endocrinology, Diabetes and Metabolism 58
Replace Jason Kirk with:
Jason Kirk United States
Natacha Bohin United States
Verónica Calvo United States
Enzo Gallo Italy
Shi‐Ming Chang United States
Xiaomei Sui China
Azadeh Arabi Iran
Jason P. Frazier United States
Kristy Miskimen United States
Guillaume Rieunier United Kingdom
Boris Freydin relative to Jason Kirk United States Jason Kirk's profile →
Citations per field
00.5×2.5×
Jason Kirk · 1×
Citations per year

Countries citing papers authored by Boris Freydin

Since Specialization
Citations

This map shows the geographic impact of Boris Freydin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Freydin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Freydin more than expected).

Fields of papers citing papers by Boris Freydin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Freydin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Freydin. The network helps show where Boris Freydin may publish in the future.

Co-authorship network of co-authors of Boris Freydin

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Freydin. A scholar is included among the top collaborators of Boris Freydin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Freydin. Boris Freydin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 12
2 6
3 17
4 3
5 39
6 12
7 59
8 96
9 79
10 0
11 1
12 21
13 38
14 80
15 3
16 3
17 1

About Boris Freydin

Boris Freydin is a scholar working on Biophysics, Oncology and Cancer Research, having authored 17 papers that have together received 470 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Oncology (274 citations), Cancer Research (117 citations) and Molecular Biology (241 citations). Boris Freydin has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Agnieszka K. Witkiewicz, Hallgeir Rui, Terry Hyslop, Jonathan R. Brody, Charles J. Yeo, Inna Chervoneva, Amy R. Peck, Jeffrey A. Hooke, Albert J. Kovatich and Craig D. Shriver. Their work appears in journals such as Journal of Clinical Oncology, Bioinformatics and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026